SKIN (SKIN)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$251.64M
EV / Sales0.85
EV / EBITDA5.70
EV / Operating Cash Flow8.70
EV / Free Cash Flow9.19

Return Metrics (TTM)

Return on Equity (ROE)-9.41%
Return on Assets (ROA)-1.27%
Return on Invested Capital (ROIC)-2.49%
Return on Capital Employed (ROCE)-3.33%

Yield Metrics

Earnings Yield-6.88%
Free Cash Flow Yield30.83%

Balance Sheet Strength

Net Debt / EBITDA3.69
Current Ratio1.79
Working Capital$122.50M
Tangible Asset Value-$103.80M
Net Current Asset Value-$140.30M

Working Capital Efficiency

Days Sales Outstanding24.96
Days Payables Outstanding55.84
Operating Cycle (Days)192.49
Cash Conversion Cycle136.65

Capital Allocation

CapEx / Revenue0.52%
CapEx / Operating Cash Flow5.34%
R&D / Revenue1.94%
SG&A / Revenue66.54%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin65.28%
Operating Margin-6.92%
Net Profit Margin-3.16%

Solvency

Debt / Equity6.20
Quick Ratio1.40
Cash Ratio1.25

Per Share

Revenue / Share$2.38
FCF / Share$0.29
PE Ratio-17.38